The proteins BRCA1 and BRCA2 are major proteins involved in maintaining the integrity of HRR processes12, and epithelial ovarian cancers with deficiencies in BRCA1/2 show increased sensitivity to platinum therapy13. Here, BRCA1 is linked to ovarian carcinoma.